Cargando…
The Biomarkers for Acute Myocardial Infarction and Heart Failure
The use of a large number of cardiovascular biomarkers, meant to complement the use of the electrocardiogram, echocardiography cardiac imaging, and clinical symptom assessment, has become a routine in clinical diagnosis, differential diagnosis, risk stratification, and prognosis and guides the manag...
Autores principales: | Wang, Xi-Ying, Zhang, Fen, Zhang, Chi, Zheng, Liang-Rong, Yang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988690/ https://www.ncbi.nlm.nih.gov/pubmed/32016113 http://dx.doi.org/10.1155/2020/2018035 |
Ejemplares similares
-
Serum HMGB1 is a biomarker for acute myocardial infarction with or without heart failure
por: Wahid, Abdul, et al.
Publicado: (2023) -
Identification of biomarkers and immune infiltration in acute myocardial infarction and heart failure by integrated analysis
por: Liu, Wei, et al.
Publicado: (2023) -
lncRNA-NRF is a Potential Biomarker of Heart Failure After Acute Myocardial Infarction
por: Yan, Li, et al.
Publicado: (2020) -
Macrophage Activities in Myocardial Infarction and Heart Failure
por: Duncan, Sophia Esi, et al.
Publicado: (2020) -
Biomarkers in acute myocardial infarction
por: Chan, Daniel, et al.
Publicado: (2010)